- Home
- TPH vs CPRX Comparison
TPH vs CPRX Comparison
Compare TPH & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- CPRX
- Stock Information
- Founded
- TPH 2009
- CPRX 2002
- Country
- TPH United States
- CPRX United States
- Employees
- TPH N/A
- CPRX N/A
- Industry
- TPH Homebuilding
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- CPRX Health Care
- Exchange
- TPH Nasdaq
- CPRX Nasdaq
- Market Cap
- TPH 2.9B
- CPRX 2.6B
- IPO Year
- TPH N/A
- CPRX 2006
- Fundamental
- Price
- TPH $32.45
- CPRX $24.46
- Analyst Decision
- TPH Buy
- CPRX Strong Buy
- Analyst Count
- TPH 5
- CPRX 7
- Target Price
- TPH $43.00
- CPRX $32.29
- AVG Volume (30 Days)
- TPH 1.0M
- CPRX 1.5M
- Earning Date
- TPH 04-24-2025
- CPRX 05-07-2025
- Dividend Yield
- TPH N/A
- CPRX N/A
- EPS Growth
- TPH 40.00
- CPRX 107.94
- EPS
- TPH 4.83
- CPRX 1.31
- Revenue
- TPH $4,492,870,000.00
- CPRX $491,734,000.00
- Revenue This Year
- TPH N/A
- CPRX $15.17
- Revenue Next Year
- TPH $6.89
- CPRX $9.61
- P/E Ratio
- TPH $6.69
- CPRX $18.67
- Revenue Growth
- TPH 20.93
- CPRX 23.49
- 52 Week Low
- TPH $30.25
- CPRX $14.47
- 52 Week High
- TPH $47.78
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- TPH 50.15
- CPRX 59.36
- Support Level
- TPH $31.20
- CPRX $23.52
- Resistance Level
- TPH $32.96
- CPRX $26.16
- Average True Range (ATR)
- TPH 0.75
- CPRX 0.88
- MACD
- TPH 0.19
- CPRX 0.12
- Stochastic Oscillator
- TPH 74.11
- CPRX 68.05
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.